A new study by researchers in the Department of Clinical Neuroscience, Karolinska Institutet, has identified 18 potential drug targets for the treatment of multiple sclerosis. The study may pave the ...

In healthy adults, a single low dose of IMP761 continues to be safe and appears to reduce the activity of T-cells, a clinical ...

Older men with MS who used androgen-modifying therapies showed unexpectedly sustained or increased disease activity in a ...

UC Riverside study may lead to new treatments for multiple sclerosis. Multiple sclerosis (MS) affects an estimated 2.3 ...

A study of twins reveals two gut bacteria linked to multiple sclerosis, offering new targets for future treatments.

A 16-year-old Newburgh boy is battling a rare life-altering disease. His family says time is running out for his health. The ...

Multiple Sclerosis MS is an autoimmune condition that can remain undetected for years A doctor explains how long MS can stay ...

TG Therapeutics, Inc.'s BRIUMVI saw Q1 2025 revenue surge 137% YoY. Click to learn about TGTX growth, upcoming trials, and ...

The  (MSAA) is pleased to provide vital services and resources to individuals affected by MS, their families, and care ...

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced the initiation of two new clinical trials to investigate the efficacy and safety of nemolizumab in treating patients ...